Financing
Proceeds from issuance of shares
Medtronic Proceeds from issuance of shares decreased by 12.0% to $95.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $89.00M to $95.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from issuance of shares shows relatively stable performance with a 1.7% CAGR.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026Aug 26, 2025
How to read this metric
An increase suggests capital raising for growth or balance sheet strengthening, while a decrease is typical for mature companies focusing on buybacks.
Detailed definition
Cash inflows generated from the issuance of common or preferred stock, including exercises of employee stock options or...
Peer comparison
Standard line item for all publicly traded companies.
Metric ID:
financing_proceeds_from_issuance_or_sale_of_equityHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $160.00M | $111.00M | $42.00M | $191.00M | $85.00M | $43.00M | $106.00M | $60.00M | $99.00M | $77.00M | $155.00M | $0.00 | $78.00M | $89.00M | $166.00M | $145.00M | $108.00M | $95.00M |
| QoQ Change | — | -30.6% | -62.2% | +354.8% | -55.5% | -49.4% | +146.5% | -43.4% | +65.0% | -22.2% | +101.3% | -100.0% | — | +14.1% | +86.5% | -12.7% | -25.5% | -12.0% |
| YoY Change | — | — | — | — | -46.9% | -61.3% | +152.4% | -68.6% | +16.5% | +79.1% | +46.2% | -100.0% | -21.2% | +15.6% | +7.1% | — | +38.5% | +6.7% |
Range$0.00 – $191.00M
CAGR-11.5%
Avg YoY Growth+4.9%
Median YoY Growth+7.1%
Current Streak3 quarters decline
Proceeds from issuance of shares at Other Companies
Frequently Asked Questions
- What is Medtronic's proceeds from issuance of shares?
- Medtronic (MDT) reported proceeds from issuance of shares of $95.00M in Q2 2025.
- How has Medtronic's proceeds from issuance of shares changed year-over-year?
- Medtronic's proceeds from issuance of shares increased by 6.7% year-over-year, from $89.00M to $95.00M.
- What is the long-term trend for Medtronic's proceeds from issuance of shares?
- Over 4 years (2021 to 2025), Medtronic's proceeds from issuance of shares has grown at a 1.7% compound annual growth rate (CAGR), from $474.00M to $508.00M.
- What does proceeds from issuance of shares mean?
- Cash received from selling company shares.